Assessment of cognitive impairment in long-term oxygen therapy-dependent COPD patients
- PMID: 26491279
- PMCID: PMC4598205
- DOI: 10.2147/COPD.S88326
Assessment of cognitive impairment in long-term oxygen therapy-dependent COPD patients
Abstract
Background: A number of studies have shown that COPD, particularly in its later and more severe stages, is associated with various cognitive deficits. Thus, the primary goal of the present study was to elucidate the extent of cognitive impairment in patients with long-term oxygen therapy-dependent (LTOTD) COPD. In addition, this study aimed to determine the effectiveness of two cognitive screening tests, the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA), for COPD patients and the ability of oxygen therapy to mitigate COPD-related deficits in cognitive function.
Methods: The present study enrolled 45 subjects: 24 nonuser and 21 regular-user LTOTD-COPD patients. All subjects had a similar grade of education, and there were no significant differences regarding age or sex. The MoCA (cutoff: <26 points) and MMSE (cutoff: ≤24 points) scores were compared between these two groups.
Results: The nonuser LTOTD-COPD group had a significantly lower MoCA score than that of the regular-user LTOTD-COPD group (19.38±2.99 vs 21.68±2.14, respectively) as well as a significantly lower MMSE score. Moreover, the absence of supplemental oxygen therapy increased the risk of cognitive impairment (MoCA, P=0.007 and MMSE, P=0.014), and the MoCA and MMSE scores significantly correlated with the number of emergency admissions and the number of hospitalizations in the last year.
Conclusion: In the present study, the nonuser LTOTD-COPD group exhibited a significant decrease in cognitive status compared with the regular-user LTOTD-COPD group. This suggests that the assessment of cognitive function in nonuser LTOTD-COPD patients and the use of protective strategies, such as continuous supplemental oxygen treatment, should be considered during the management of COPD in this population. In addition, the MoCA score was superior to the MMSE score for the determination of cognitive impairment in the nonuser LTOTD-COPD patients.
Keywords: COPD; cognitive impairment; long-term oxygen therapy-dependent.
Figures


Similar articles
-
Cognitive dysfunction among patients in chronic obstructive pulmonary disease: Effects of exacerbation and long-term oxygen therapy.Clin Respir J. 2020 Dec;14(12):1137-1143. doi: 10.1111/crj.13250. Epub 2020 Aug 24. Clin Respir J. 2020. PMID: 32772486
-
Suitability of the Montreal cognitive assessment versus the mini-mental state examination in detecting vascular cognitive impairment.J Stroke Cerebrovasc Dis. 2013 Aug;22(6):737-41. doi: 10.1016/j.jstrokecerebrovasdis.2012.01.001. Epub 2012 Feb 4. J Stroke Cerebrovasc Dis. 2013. PMID: 22306380
-
Factors Influencing Cognitive Function in Subjects With COPD.Respir Care. 2016 Aug;61(8):1044-50. doi: 10.4187/respcare.04403. Epub 2016 Mar 1. Respir Care. 2016. PMID: 26932385
-
The relationship between cognitive function and arterial partial pressure O2 in patients with COPD: A meta-analysis.Medicine (Baltimore). 2018 Jan;97(4):e9599. doi: 10.1097/MD.0000000000009599. Medicine (Baltimore). 2018. PMID: 29369175 Free PMC article. Review.
-
[Cognitive dysfunction in patients with chronic obstructive pulmonary disease].Wiad Lek. 2007;60(3-4):143-7. Wiad Lek. 2007. PMID: 17726866 Review. Polish.
Cited by
-
Cognitive impairment in COPD: should cognitive evaluation be part of respiratory assessment?Breathe (Sheff). 2017 Mar;13(1):e1-e9. doi: 10.1183/20734735.001417. Breathe (Sheff). 2017. PMID: 29184593 Free PMC article. Review.
-
Mesenchymal stem cell-derived exosomes-a promising therapeutic approach to improve neurocognitive disorders in chronic obstructive pulmonary disease.Stem Cell Res Ther. 2025 Jun 20;16(1):314. doi: 10.1186/s13287-025-04457-5. Stem Cell Res Ther. 2025. PMID: 40542422 Free PMC article. Review.
-
Interactions between Cognitive, Affective, and Respiratory Profiles in Chronic Respiratory Disorders: A Cluster Analysis Approach.Diagnostics (Basel). 2024 May 30;14(11):1153. doi: 10.3390/diagnostics14111153. Diagnostics (Basel). 2024. PMID: 38893678 Free PMC article.
-
Ketone monoester attenuates declines in cognitive performance and oxygen saturation during acute severe hypoxic exposure under resting conditions.Exp Physiol. 2024 Oct;109(10):1672-1682. doi: 10.1113/EP091794. Epub 2024 Aug 27. Exp Physiol. 2024. PMID: 39190580 Free PMC article. Clinical Trial.
-
Preliminary study of assessing cognitive impairment in older patients with chronic obstructive pulmonary disease by using a cognitive functional assessment tool via a touchscreen personal computer.Multidiscip Respir Med. 2023 Feb 1;18:892. doi: 10.4081/mrm.2023.892. eCollection 2023 Jan 17. Multidiscip Respir Med. 2023. PMID: 36798953 Free PMC article.
References
-
- Antonelli-Incalzi R, Corsonello A, Trojano L, et al. Screening of cognitive impairment in chronic obstructive pulmonary disease. Dement Geriatr Cogn Disord. 2007;23(4):264–270. - PubMed
-
- Antonelli-Incalzi R, Corsonello A, Pedone C, et al. Drawing impairment predicts mortality in severe COPD. Chest. 2006;130(6):1687–1694. - PubMed
-
- Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J. 2010;35(4):913–922. - PubMed
-
- Heaton RK, Grant I, McSweeny AJ, Adams KM, Petty TL. Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1983;143(10):1941–1947. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical